Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Tern PLC: Statement re: Device Authority Forecasts from September 2017

3 Aug 2018 07:00

Tern PLC (TERN) Tern PLC: Statement re: Device Authority Forecasts from September 2017 03-Aug-2018 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


August 2018

Tern Plc (AIM: TERN)

 

Statement re: Device Authority Forecasts from September 2017

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), seeks to clarify the RNS dated 29 September 2017, which included, inter alia, financial information for Device Authority Limited ("DA"), one of Tern's investee companies and in which Tern has a 56.8 per cent. holding.

 

The RNS of 29 September 2017 reproduced actual and forecast financial information regarding DA which DA's brokers, US Capital Partners, had made available on its website in order to promote a fundraising for DA. The forecasts were made public by Tern in order to ensure no disparity of information in the market. Both the RNS and the information on US Capital Partners website highlighted that the forecasts were conditional upon a full and successful $10m raise. The forecasts were prepared by the management of DA and the historic numbers were unaudited.

 

Tern announced on 1 February 2018 that the DA fundraise had not yet completed and was ongoing, signalling that further announcements would be made in respect of the fundraise. Tern announced its final results for the year ended 31 December 2017 on 27 March 2018, in which it was confirmed that DA did not achieve the announced revenue targets for 2017, and the DA fundraising had not yet been completed.

 

For the avoidance of any doubt, as the forecasts presented in the RNS of 29 September 2017 were conditional upon a successful and full completion of the proposed fundraise, Tern confirms that the DA forecasts of September 2017 are no longer relevant, and that DA does not have any forecast numbers in the public domain at the current time. The shareholders of DA remain supportive and have provided the company with $2,160,134 of additional funding by way of convertible loan notes since 30 November 2017, and further outside investment continues to be sought. Tern is pleased with the progress DA is making as outlined, for example, in the portfolio update announced on 16 May 2018 and subsequent announcements regarding the development of the strategic partnership with Thales.

 

An update on DA's performance will be provided in the Company's half yearly report for the six months ended 30 June 2018 which will be announced in the first half of September 2018.

 

 

Enquiries

 

Tern Plc

Al Sisto/Sarah Payne

Via Redleaf Communications

 

WH Ireland

(NOMAD and joint broker)

Mike Coe/Ed Allsopp

 

Tel: 0117 945 3470

 

Whitman Howard

(Joint broker)

Nick Lovering/Francis North

 

Tel: 020 7659 1234

 

Redleaf Communications

Elisabeth Cowell/Fiona Norman

 

Tel: 020 3757 6880

 


ISIN:GB00BFPMV798
Category Code:MSCU
TIDM:TERN
LEI Code:2138005F87SODHL9CQ36
Sequence No.:5829
EQS News ID:710609
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.